S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
A Review on Synthetic Approaches of Phenanthridine
|
Letters In Organic Chemistry
|
Nilesh Kshirsagar; Ratnamala Sonawane; Ismail Pathan; Ganesh Kamble; Girdhar Pal Singh
|
10.2174/1570178618666210218211424
|
0
|
2 |
Drug-induced neuropsychiatric adverse events using post-marketing surveillance.
|
Current Clinical Pharmacology
|
Tomohito Wakabayashi; Takahiro Nakatsuji; Hiroko Kambara; Iku Niinomi; Saki Oyama; Ayaka Inada; Sayaka Ueno; Mayako Uchida; Kazunori Iwanaga; Tatsuya Iida; Keiko Hosohata
|
10.2174/1574884716666210215104540
|
0
|
3 |
Effects of an Antihypertensive Combination in Japanese Hypertensive Outpatients Based on the Long-acting Calcium Channel Blocker Benidipine on Vascular and Renal Events: A Sub-analysis of the COPE Trial.
|
Current Hypertension Reviews
|
Seiji Umemoto; Toshio Ogihara; Masunori Matsuzaki; Hiromi Rakugi; Kazuyuki Shimada; Koichi Hayashi; Hirofumi Makino; Yasuo Ohashi; Takao Saruta
|
10.2174/1573402116666200129130151
|
0
|
4 |
Molecular Mechanisms Involved in the Progression and Protection of Osteoarthritis
|
Current Molecular Pharmacology
|
Yoshifumi Takahata; Tomohiko Murakami; Kenji Hata; Riko Nishimura
|
10.2174/1874467213666200417122933
|
0
|
5 |
Protective Potential of Ginkgo biloba Against an ADHD-like Condition.
|
Current Molecular Pharmacology
|
Garima Sharma; Naveen Sharma; Bao Trong Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Yukio Yoneda; Eun-Joo Shin; Hyoung-Chun Kim
|
10.2174/1874467213666200424152454
|
0
|
6 |
Kinetic and Thermodynamic Study of Plantaricin IIA-1A5, a Bacteriocin Produced by Indonesian Probiotic Lactobacillus plantarum IIA-1A5.
|
Protein And Peptide Letters
|
Muhamad Arifin; Cahyo Budiman; Kazuhito Fujiyama; Irma Isnafia Arief
|
10.2174/0929866527999201123213841
|
0
|
7 |
Whole genome analysis of extensively drug-resistant Acinetobacter bau-mannii clinical isolates in Thailand.
|
Infectious Disorders Drug Targets
|
Peechanika Chopjitt; Anusak Kerdsin; Dan Takeuchi; Rujirat Hatrongjit; Parichart Boueroy; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
|
10.2174/1871526520999201116201911
|
1
|
8 |
Synthesis of TFA-protected α-Amino Acid Chloride via a Vilsmeier Reagent for Friedel–Crafts Acylation
|
Letters In Organic Chemistry
|
Zetryana Puteri Tachrim; Kazuhiro Oida; Fumina Ohashi; Natsumi Kurokawa; Lei Wang; Takeyuki Suzuki; Makoto Hashimoto
|
10.2174/1570178617666200207111127
|
1
|
9 |
Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
|
Current Signal Transduction Therapy
|
Eriko Osaki; Shinya Mizuno
|
10.2174/1574362413666180724134204
|
0
|
10 |
Innovative Therapeutic Strategies in the Molecular Targeting Era.
|
Current Medicinal Chemistry
|
Jun-Ichi Nishimura
|
10.2174/092986732725200619144223
|
0
|
11 |
Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
|
Current Gene Therapy
|
Ryuichi Morishita; Munehisa Shimamura; Yasushi Takeya; Hironori Nakagami; Mitsuaki Chujo; Tetsuya Ishihama; Ei Yamada; Hiromi Rakugi
|
10.2174/1566523220666200516171447
|
3
|
12 |
Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
|
Current Medicinal Chemistry
|
Masakazu Sugishima; Kei Wada; Keiichi Fukuyama
|
10.2174/0929867326666181217142715
|
4
|
13 |
Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction.
|
Current Protein & Peptide Science
|
Songjie Cai; Jing Zhao; Takuya Ueno; Anil Chandraker
|
10.2174/1389203720666190507095759
|
1
|
14 |
Establishment of Novel Cells Stably Secreting Various Human IL-18 Recombinant Proteins.
|
Current Pharmaceutical Biotechnology
|
Asuka Kumagai; Kenji Shimizu; Riho Kurata; Xiaofeng Cui; Takayuki Isagawa; Masamitsu Harada; Jun Nagai; Yasuhiro Yoshida; Kei-ichi Ozaki; Norihiko Takeda; Hiroaki Semba; Tomo Yonezawa
|
10.2174/1389201020666190206203640
|
1
|
15 |
Meet Our Editor-in-Chief
|
Immunology, Endocrine & Metabolic Agents In Medicinal Chemistry
|
Ryuichi Morishita
|
10.2174/187152221801180905151147
|
3
|
16 |
A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression.
|
Current Pharmaceutical Design
|
Kazuya Masuda; Tadamitsu Kishimoto
|
10.2174/1381612824666180426103753
|
4
|
17 |
Child-rearing Support Provided by Public Health Nurses to People with Mental Illness: Qualitative Descriptive Study.
|
The Open Nursing Journal
|
Masako Kageyama; Keiko Yokoyama
|
10.2174/1874434601812010162
|
0
|
18 |
Establishment of Novel Reporter Cells Stably Maintaining Transcription Factor-driven Human Secreted Alkaline Phosphatase Expression
|
Current Pharmaceutical Biotechnology
|
Riho Kurata; Asuka Kumagai; Xiaofeng Cui; Masamitsu Harada; Jun Nagai; Yasuhiro Yoshida; Kei-ichi Ozaki; Yoshimasa Tanaka; Tomo Yonezawa
|
10.2174/1389201019666180418093334
|
5
|
19 |
The Clock Genes Are Involved in The Deterioration of Atopic Dermatitis after Day-and-Night Reversed Physical Stress in NC/Nga Mice
|
The Open Biochemistry Journal
|
Keiichi Hiramoto; Kumi Orita; Yurika Yamate; Emiko Kasahara; Satoshi Yokoyama; Eisuke F. Sato
|
10.2174/1874091x01812010087
|
3
|
20 |
How Do Dendritic Cells Play the Role in Ischemia/Reperfusion Triggered Kidney Allograft Rejection.
|
Current Gene Therapy
|
Songjie Cai; Naotsugu Ichimaru; Shiro Takahara
|
10.2174/1566523218666180214095956
|
2
|
21 |
Potential Application of 5-Aryl-Substituted 2-Aminobenzamide Type of HDAC1/2- Selective Inhibitors to Pharmaceuticals.
|
Current Pharmaceutical Design
|
Shinichi Uesato; Yoshiyuki Hirata; Tsutomu Sasaki
|
10.2174/1381612822666161208143417
|
2
|
22 |
Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
|
Current Vascular Pharmacology
|
Eiki Woo; Ryuji Kato; Hideki Imano; Yuji Fujiwara; Yoshio Ijiri; Yoshikatsu Okada; Takehiro Yamaguchi; Yasukatsu Izumi; Minoru Yoshiyama; Takahiro Katsumata; Tetsuya Hayashi
|
10.2174/1570161115666170427154217
|
4
|
23 |
Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
|
CNS & Neurological Disorders Drug Targets
|
Yukihiro Ohno; Kentaro Tokudome
|
10.2174/1871527316666170404115027
|
14
|
24 |
Estimation of the Basic Reproduction Number of Novel Influenza A (H1N1) pdm09 in Elementary Schools Using the SIR Model.
|
The Open Nursing Journal
|
Daisuke Furushima; Shoko Kawano; Yuko Ohno; Masayuki Kakehashi
|
10.2174/1874434601711010064
|
5
|
25 |
The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells.
|
Drug Metabolism Letters
|
Tetsuo Sasabe; Shinichiro Maeda; Kenichi Kishida; Mariko Yamano; Yoshihiro Miwa; Toshihiro Sugiyama
|
10.2174/1872312811666170127160931
|
0
|
26 |
The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
|
CNS & Neurological Disorders Drug Targets
|
Yuko Okamoto; Makoto Ishitobi; Yuji Wada; Hirotaka Kosaka
|
10.2174/1871527315666160413120845
|
21
|
27 |
Dynamical Behavior of the Charge Transfer Phase Transition in Dithiooxalato-Bridged Iron Mixed-Valence System
|
Current Inorganic Chemistry
|
Masaya Enomoto; Isao Watanabe; Norimichi Kojima
|
10.2174/1877944105666150910200754
|
0
|
28 |
Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart.
|
Current Gene Therapy
|
Shigeru Miyagawa; Satsuki Fukushima; Yukiko Imanishi; Takuji Kawamura; Noriko Mochizuki-Oda; Shigeo Masuda; Yoshiki Sawa
|
10.2174/1566523216666160119094143
|
16
|
29 |
The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study.
|
Current Molecular Medicine
|
Kyosuke Uno; Daisuke Nishizawa; Seunghee Seo; K. Takayama; Shohei Matsumura; Norio Sakai; Kazutaka Ohi; Toshitaka Nabeshima; Ryota Hashimoto; Norio Ozaki; J. Hasegawa; Naomi Sato; Fumihiko Tanioka; Haruhiko Sugimura; Ken-ichi Fukuda; Susumu Higuchi; Hiros
|
10.2174/1566524015666150330145722
|
4
|
30 |
Imaging Genetics and Psychiatric Disorders
|
Current Molecular Medicine
|
Ryota Hashimoto; Kazutaka Ohi; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Yoshifumi Watanabe; Masaki Fukunaga; Masatoshi Takeda
|
10.2174/1566524015666150303104159
|
29
|
31 |
Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.
|
Immunology, Endocrine & Metabolic Agents In Medicinal Chemistry
|
Fumihiro Sanada; Yoshiaki Taniyama; Junya Azuma; Ikeda-Iwabe Yuka; Yasuhiro Kanbara; Masaaki Iwabayashi; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/1871522213999131231105139
|
9
|
32 |
Investigations on Electronic States of Molecule-based Compounds by High-Pressure AC Calorimetry
|
Current Inorganic Chemistry
|
Yasuhiro Nakazawa; Ryo Yoshimoto; Shuhei Fukuoka; Satoshi Yamashita
|
10.2174/1877944104666140825204911
|
3
|
33 |
Phase Transitions Due to Charge Transfer in Mixed-Valence Assembled Metal Complexes, A[Fe II Fe III I(dto) 3 ] (A = (n-C n H 2n+1 ) 4 N, Spiropyran; dto = C 2 O 2 S 2 )
|
Current Inorganic Chemistry
|
Norimichi Kojima; Miho Itoi; Yuji Miyazaki
|
10.2174/1877944104666140825203502
|
1
|
34 |
Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension.
|
Current Hypertension Reviews
|
Kei Kamide
|
10.2174/1573402110666140812122349
|
19
|
35 |
Review: Evidence-based Clinical Research of Anti-obesity Supplements in Japan.
|
Immunology, Endocrine & Metabolic Agents In Medicinal Chemistry
|
Asuka Yasueda; Toshinori Ito; Kazuhisa Maeda
|
10.2174/1871522213666131118221347
|
3
|
36 |
Potential effect of angiotensin II receptor blockade in adipose tissue and bone.
|
Current Pharmaceutical Design
|
Hironori Nakagami; Mariana Kiomy Osako; Ryuichi Morishita
|
10.2174/1381612811319170011
|
13
|
37 |
Angiotensin II type 1 and type 2 receptor-induced cell signaling.
|
Current Pharmaceutical Design
|
Hiroshi Akazawa; Masamichi Yano; Chizuru Yabumoto; Yoko Kudo-Sakamoto; Issei Komuro
|
10.2174/1381612811319170003
|
28
|
38 |
Angiotensin (1-7) and other Angiotensin Peptides
|
Current Pharmaceutical Design
|
Mitsuru Ohishi; Koichi Yamamoto; Hiromi Rakugi
|
10.2174/1381612811319170013
|
21
|
39 |
Gene polymorphism of angiotensin II type 1 and type 2 receptors.
|
Current Pharmaceutical Design
|
Tomohiro Katsuya; Ryuichi Morishita
|
10.2174/1381612811319170004
|
11
|
40 |
The Glial Sodium-Calcium Exchanger: A New Target for Nitric Oxide- Mediated Cellular Toxicity
|
Current Protein & Peptide Science
|
Kazuhiro Takuma; Yukio Ago; Toshio Matsuda
|
10.2174/1389203711314010007
|
14
|
41 |
Coherent anti-stokes Raman scattering microscopy for high speed non- staining biomolecular imaging.
|
Current Pharmaceutical Biotechnology
|
Mamoru Hashimoto; Takeo Minamikawa; Tsutomu Araki
|
10.2174/138920113805219412; 10.2174/1389201011314020004
|
2
|
42 |
Metallic nanoparticles as SERS agents for biomolecular imaging.
|
Current Pharmaceutical Biotechnology
|
Jun Ando; Katsumasa Fujita
|
10.2174/138920113805219377; 10.2174/1389201011314020003
|
4
|
43 |
Cell sheet technology for heart failure.
|
Current Pharmaceutical Biotechnology
|
Yoshiki Sawa; Shigeru Miyagawa
|
10.2174/1389201011314010009; 10.2174/138920113804805395
|
11
|
44 |
Single Molecular Observation of DNA and DNA Complexes by Atomic Force Microscopy
|
Current Pharmaceutical Biotechnology
|
Takuya Matsumoto; Eriko Mikamo-Satoh; Akihiko Takagi; Tomoji Kawai
|
10.2174/138920101314151120122713
|
1
|
45 |
Synthesis and Application of Visible Light Sensitive Azobenzene
|
Current Pharmaceutical Biotechnology
|
Shinjiro Sawada; Nobuo Kato; Kunihiro Kaihatsu
|
10.2174/138920101314151120122912
|
7
|
46 |
IL-4 and IL-12 Polymorphisms are Associated with Response to Suplatast Tosilate, a Th2 Cytokine Inhibitor, in Patients with Atopic Dermatitis
|
The Open Dermatology Journal
|
Hideki Nagase; Yoshinori Nakachi; Keiji Ishida; Mamoru Kiniwa; Satoshi Takeuchi; Ichiro Katayama; Yoshinari Matsumoto; Fukumi Furukawa; Shin Morizane; Sakae Kaneko; Yoshiki Tokura; Motoi Takenaka; Yutaka Hatano; Yoshiki Miyachi
|
10.2174/1874372201206010042
|
1
|
47 |
Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
|
Current Topics In Medicinal Chemistry
|
Mariana Kiomy Osako; Hironori Nakagami; Ryuichi Morishita
|
10.2174/156802612803531397
|
20
|
48 |
Nucleic acid drugs for preventing restenosis after coronary revascularization.
|
Current Topics In Medicinal Chemistry
|
Takashi Miyake; Hironori Nakagami; Ryuichi Morishita
|
10.2174/156802612803531324
|
3
|
49 |
Therapeutic option of plasmid-DNA based gene transfer.
|
Current Topics In Medicinal Chemistry
|
Yoshiaki Taniyama; Junya Azuma; Yasuo Kunugiza; Kazuma Iekushi; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/156802612803531342
|
21
|
50 |
Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel disease.
|
Current Gene Therapy
|
Kazunari Ozaki; Hirofumi Makino; Motokuni Aoki; Takashi Miyake; Natsuki Yasumasa; Mariana Kiomy Osako; Hironori Nakagami; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/156652312803519814
|
13
|
51 |
Development of Nucleic Acid Drugs for Neurological Disorders
|
Current Topics In Medicinal Chemistry
|
Munehisa Shimamura; Naoyuki Sato; Hironori Nakagami; Yoshiaki Taniyama; Ryuichi Morishita
|
10.2174/156802612803531405
|
3
|
52 |
Sleep Debt Must be Paid Off: Relationship Between Sleep Loss and Mental Health Among Japanese Workers
|
The Open Sleep Journal
|
Akira Mikami
|
10.2174/1874620901205010025
|
0
|
53 |
A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
|
Anti-cancer Agents In Medicinal Chemistry
|
Koshi Kawakami; Miho Hattori; Takatsugu Inoue; Yuriko Maruyama; Junko Ohkanda; Nobuo Kato; Miki Tongu; Takaya Yamada; Miho Akimoto; Keizo Takenaga; Takeshi Sassa; Junji Suzumiy; Yoshio Honma
|
10.2174/187152012802650264
|
24
|
54 |
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells
|
Current Cancer Drug Targets
|
K. Koike; Y. Ueda; H. Hase; K. Kitae; Y. Fusamae; S. Masai; T. Inagaki; Y. Saigo; S. Hirasawa; K. Nakajima; I. Ohshio; Y. Makino; N. Konishi; H. Yamamoto; K. Tsujikawa
|
10.2174/156800912802429283
|
28
|
55 |
Importance of Assessing the Effect of Statins on the Function of High- Density Lipoproteins on Coronary Plaque
|
Cardiovascular & Hematological Disorders Drug Targets
|
Ken Kishida; Tohru Funahashi; Iichiro Shimomura
|
10.2174/187152912801823156
|
15
|
56 |
Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin.
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Ken Kishida; Tohru Funahashi; Iichiro Shimomura
|
10.2174/187153012800493468
|
56
|
57 |
Risk Factors for Cardiovascular Events in Japanese Patients Treated with Fluvastatin from the Long-Term Event Monitoring (LEM) Study
|
Current Vascular Pharmacology
|
Ryuichi Morishita; Hiroshige Itakura; Noriaki Nakaya; Masayuki Yoshida; Masato Odawara; Atsuhiro Ichihara; Kyoichi Mizuno
|
10.2174/157016112799305049
|
4
|
58 |
Clinical Importance of Assessment of Type 2 Diabetes Mellitus with Visceral Obesity. A Japanese Perspective
|
Current Diabetes Reviews
|
Ken Kishida; Tohru Funahashi; Iichiro Shimomura
|
10.2174/157339912799424546
|
20
|
59 |
Primary Screening of Single Nucleotide Polymorphisms in Human Calreticulin 3 (CALR3)
|
The Open Andrology Journal
|
Shinji Irie; Junko Nakamura; Yasushi Miyagawa; Akira Tsujimura; Hidenobu Okuda; Keisuke Yamamoto; Shinichiro Fukuhara; Iwao Yoshioka; Kiuchi Hiroshi; Yasuhiro Matsuoka; Tetsuya Takao; Norio Nonomura; Masahito Ikawa; Keizo Tokuhiro; Masaru Okabe; Tomomi Sh
|
10.2174/1876827x01103010030
|
3
|
60 |
Novel strategies to improve DNA vaccine immunogenicity.
|
Current Gene Therapy
|
Cevayir Coban; Kouji Kobiyama; Taiki Aoshi; Fumihiko Takeshita; Toshihiro Horii; Shizuo Akira; Ken J. Ishii
|
10.2174/156652311798192815
|
92
|
61 |
Plasmid DNA-based gene transfer with ultrasound and microbubbles.
|
Current Gene Therapy
|
Yoshiaki Taniyama; Junya Azuma; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/156652311798192851
|
8
|
62 |
Development of liposomes and pseudovirions with fusion activity for efficient gene delivery.
|
Current Gene Therapy
|
Yasufumi Kaneda
|
10.2174/156652311798192789
|
7
|
63 |
Peptides as tight junction modulators.
|
Current Pharmaceutical Design
|
Azusa Takahashi; Masuo Kondoh; Miki Kodaka; Kiyohito Yagi
|
10.2174/138161211797416084
|
8
|
64 |
Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.
|
Current Aging Science
|
Naoyuki Sato; Shuko Takeda; Kozue Uchio-Yamada; Hironori Ueda; Tomomi Fujisawa; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/1874609811104020118
|
55
|
65 |
Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.
|
Inflammation & Allergy Drug Targets
|
Kenichi Watanabe; Vijayakumar Sukumaran; Punniyakoti T. Veeraveedu; Rajarajan Amirthalingam Thandavarayan; Narasimman Gurusamy; Meilei Ma; Wawaimuli Arozal; Flori R. Sari; Arun Prasath Lakshmanan; Somasundaram Arumugam; Vivian Soetikno; Varatharajan Rajav
|
10.2174/187152811795564091
|
26
|
66 |
Targeting mTOR signaling pathway in ovarian cancer.
|
Current Medicinal Chemistry
|
Seiji Mabuchi; Takeshi Hisamatsu; Tadashi Kimura
|
10.2174/092986711796150450
|
31
|
67 |
HGF as Angiogenic Factor and Therapeutic Approach
|
Current Signal Transduction Therapy
|
Yoshiaki Taniyama; Yasushi Takeya; Junya Azuma; Kazuma Iekushi; Fumihiro Sanada; Hiroshi Kusunoki; Keita Okayama; Nobutaka Koibuchi; Hiromi Rakugi; Ryuichi Morishita
|
10.2174/157436211795660016
|
0
|
68 |
Claudin as a Target for Drug Development
|
Current Medicinal Chemistry
|
Azusa Takahashi; Masuo Kondoh; Hidehiko Suzuki; Kiyohito Yagi
|
10.2174/092986711795496809
|
20
|
69 |
PACAP is Implicated in the Stress Axes
|
Current Pharmaceutical Design
|
Hitoshi Hashimoto; Norihito Shintani; Mamoru Tanida; Atsuko Hayata; Ryota Hashimoto; Akemichi Baba
|
10.2174/138161211795589382
|
53
|
70 |
Obesity and gastrointestinal hormones-dual effect of angiotensin II receptor blockade and a partial agonist of PPAR-γ.
|
Current Vascular Pharmacology
|
Hironori Nakagami; Ryuichi Morishita
|
10.2174/157016111794519291
|
9
|
71 |
Promising Targets for Anti-Hepatitis C Virus Agents
|
Current Medicinal Chemistry
|
Takeshi Yoshida; Masuo Kondoh; Kiyohito Yagi
|
10.2174/092986711795029672
|
4
|
72 |
New concept of vascular calcification and metabolism.
|
Current Vascular Pharmacology
|
Hironori Nakagami; Mariana Kiomy Osako; Ryuichi Morishita
|
10.2174/157016111793744742
|
12
|
73 |
Protein core adaptability: crystal structures of the cavity-filling variants of Escherichia coli RNase HI.
|
Protein And Peptide Letters
|
Masaki Tanaka; Hyongi Chon; Clement Angkawidjaja; Yuichi Koga; Kazufumi Takano; Shigenori Kanaya
|
10.2174/092986610791760342
|
8
|
74 |
New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders.
|
Central Nervous System Agents In Medicinal Chemistry
|
Yukihiro Ohno
|
10.2174/187152410791196341
|
50
|
75 |
Host innate immune responses induced by baculovirus in mammals.
|
Current Gene Therapy
|
Takayuki Abe; Yoshiharu Matsuura
|
10.2174/156652310791321279
|
44
|
76 |
Development of cathepsin inhibitors and structure-based design of cathepsin B-specific inhibitor.
|
Current Topics In Medicinal Chemistry
|
Koji Tomoo
|
10.2174/156802610791113441
|
21
|
77 |
Cell engineering and cultivation of chinese hamster ovary (CHO) cells.
|
Current Pharmaceutical Biotechnology
|
Takeshi Omasa; Masayoshi Onitsuka; Wook-Dong Kim
|
10.2174/138920110791111960
|
111
|
78 |
Pharmacogenomics of Adrenergic Receptors; from Hypertension to Heart Failure
|
The Open Hypertension Journal
|
Shinpei Nonen; Junichi Azuma; Yasushi Fujio
|
10.2174/1876526201003010014
|
0
|
79 |
Effects of Joining Conditions on Joint Strength of Cu/Cu Joint Using Cu Nanoparticle Paste
|
The Open Surface Science Journal
|
Hiroshi Nishikawa; Tomoaki Hirano; Tadashi Takemoto; Nobuhito Terada
|
10.2174/1876531901103010060
|
37
|
80 |
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
|
Anti-cancer Agents In Medicinal Chemistry
|
Yoshihiro Oka; Akihiro Tsuboi; Fumihiro Fujiki; Zheyu Li; Hiroko Nakajima; Naoki Hosen; Toshiaki Shirakata; Sumiyuki Nishida; Yusuke Oji; Ichiro Kawase; Haruo Sugiyama
|
10.2174/187152009789056958
|
19
|
81 |
Combination of MafA, PDX-1 and NeuroD is a Useful Tool to Efficiently Induce Insulin-Producing Surrogate β -Cells
|
Current Medicinal Chemistry
|
Hideaki Kaneto; Taka-aki Matsuoka; Naoto Katakami; Munehide Matsuhisa
|
10.2174/092986709788802980
|
36
|
82 |
Uptake and dynamics of infectious prion protein in the intestine.
|
Protein And Peptide Letters
|
Yasuhisa Ano; Akikazu Sakudo; Hiroyuki Nakayama; Takashi Onodera
|
10.2174/092986609787601642
|
20
|
83 |
New and emerging approaches to prion diseases.
|
Protein And Peptide Letters
|
Akikazu Sakudo
|
10.2174/092986609787601633
|
0
|
84 |
Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
|
Protein And Peptide Letters
|
Akikazu Sakudo; Kazuyoshi Ikuta
|
10.2174/092986609787601732
|
12
|
85 |
Prion protein functions and dysfunction in prion diseases.
|
Current Medicinal Chemistry
|
Akikazu Sakudo; Kazuyoshi Ikuta
|
10.2174/092986709787002673
|
30
|
86 |
"Cancer antigen WT1 protein-derived peptide"-based treatment of cancer -toward the further development.
|
Current Medicinal Chemistry
|
Yoshihiro Oka; Akihiro Tsuboi; Fumihiro Fujiki; Toshiaki Shirakata; Sumiyuki Nishida; Naoki Hosen; Hiroko Nakajima; Zheyu Li; Ichiro Kawase; Yusuke Oji; Haruo Sugiyama
|
10.2174/092986708786848631
|
17
|
87 |
Amyloid β Conformation in Aqueous Environment
|
Current Alzheimer Research
|
Kazufumi Takano
|
10.2174/156720508786898424
|
12
|
88 |
Oral Candidosis in HIV-Infected Patients
|
Current HIV Research
|
Hiroshi Egusa; Niroshani S. Soysa; Arjuna N.B. Ellepola; Hirofumi Yatani; Lakshman P. Samaranayake
|
10.2174/157016208786501445
|
54
|
89 |
A Case of Fissure-Like Pressure Ulcer on the Coccygeal Area Successfully Treated with Changing of Wound Dressing
|
The Open Dermatology Journal
|
Shigeki Inui; Satoshi Itami
|
10.2174/1874372200802010093
|
1
|
90 |
Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
|
Current Pharmaceutical Design
|
Yoshitaka Nagai; Helena Akiko Popiel
|
10.2174/138161208786404164
|
58
|
91 |
Structure, formation and propagation of amyloid fibrils.
|
Current Pharmaceutical Design
|
Yuji Goto; Hisashi Yagi; Kei-ichi Yamaguchi; Eri Chatani; Tadato Ban
|
10.2174/138161208786404146
|
30
|
92 |
Gene therapy for Multiple Myeloma
|
Current Gene Therapy
|
Yasuo Adachi; Naoko Yoshio-Hoshino; Norihiro Nishimoto
|
10.2174/156652308785160683
|
5
|
93 |
An Efficient Solution Method for 0-1 Random Fuzzy Programming Problems Considering the Relaxation Problems
|
The Open Operational Research Journal
|
Takashi Hasuike; H. Ishii; Hideki Katagiri
|
10.2174/1874243200802010038
|
4
|
94 |
Optimum Voxel Volume for Maximizing Contrast-to-Noise Ratio in BOLD Functional MRI
|
The Open Magnetic Resonance Journal
|
Norihiko Fujita; Kouji Okada; Hisashi Tanaka; Kenya Murase
|
10.2174/1874769800801010054
|
0
|
95 |
The Blockade of IL-6 Signaling in Rational Drug Design
|
Current Pharmaceutical Design
|
Yasuo Adachi; Naoko Yoshio-Hoshino; Norihiro Nishimoto
|
10.2174/138161208784246072
|
36
|
96 |
Normal cytochrome C oxidase activity in prion protein gene-deficient mice.
|
Protein And Peptide Letters
|
Akikazu Sakudo; Yojiro Taniuchi; Takanori Kobayashi; Takashi Onodera; Kazuyoshi Ikuta
|
10.2174/092986608783744298
|
2
|
97 |
Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes.
|
Current Molecular Medicine
|
Hideaki Kaneto; Taka-aki Matsuoka; Naoto Katakami; Dan Kawamori; Takeshi Miyatsuka; Kazutomi Yoshiuchi; Tetsuyuki Yasuda; Ken’ya Sakamoto; Yoshimitsu Yamasaki; Munehide Matsuhisa
|
10.2174/156652407782564408
|
74
|
98 |
Modification of apatite materials for bone tissue engineering and drug delivery carriers.
|
Current Medicinal Chemistry
|
Takuya Matsumoto; Masayuki Okazaki; Atsushi Nakahira; Jun Ichi Sasaki; Hiroshi Egusa; Taiji Sohmura
|
10.2174/092986707782023208
|
63
|
99 |
Tight Junction Modulators: Promising Candidates for Drug Delivery
|
Current Medicinal Chemistry
|
Masuo Kondoh; Kiyohito Yagi
|
10.2174/092986707782023640
|
19
|
100 |
Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
|
Current Drug Safety
|
Hiroshi Nojima; Yusuke Ohba; Yasuyuki Kita
|
10.2174/157488607781668837
|
18
|
101 |
Crucial Role of PDX-1 in Pancreas Development, β-Cell Differentiation, and Induction of Surrogate β-Cells
|
Current Medicinal Chemistry
|
Hideaki Kaneto; Takeshi Miyatsuka; Toshihiko Shiraiwa; Kaoru Yamamoto; Ken Kato; Yoshio Fujitani; Taka-aki Matsuoka
|
10.2174/092986707781058887
|
43
|
102 |
Acute cerebral blood flow variations after human cardiac arrest assessed by stable xenon enhanced computed tomography.
|
Current Neurovascular Research
|
Yoshiaki Inoue; Tadahiko Shiozaki; Taro Irisawa; Tomoyoshi Mohri; Kazuhisa Yoshiya; Hitoshi Ikegawa; Osamu Tasaki; Hiroshi Tanaka; Takeshi Shimazu; Hisashi Sugimoto
|
10.2174/156720207779940725
|
18
|
103 |
Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.
|
Endocrine, Metabolic & Immune Disorders Drug Targets
|
Hideko Nakahara; Norihiro Nishimoto
|
10.2174/187153006779025694
|
33
|
104 |
MTHFR gene polymorphism and diabetic retinopathy.
|
Current Diabetes Reviews
|
Makiko Maeda; Yasushi Fujio; Junichi Azuma
|
10.2174/1573399810602040467
|
18
|
105 |
Development of WT1 Peptide Cancer Vaccine Against Hematopoietic Malignancies and Solid Cancers
|
Current Medicinal Chemistry
|
Yoshihiro Oka; Akio Tsuboi; Manabu Kawakami; Olga A. Elisseeva; Hiroko Nakajima; Keiko Udaka; Ichiro Kawase; Yusuke Oji; Haruo Sugiyama
|
10.2174/092986706777935104
|
48
|
106 |
Recent advances in clarifying prion protein functions using knockout mice and derived cell lines.
|
Mini Reviews In Medicinal Chemistry
|
Akikazu Sakudo; Takashi Onodera; Yoshikazu Suganuma; Takanori Kobayashi; Keiichi Saeki; Kazuyoshi Ikuta
|
10.2174/138955706776876159
|
40
|
107 |
Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
|
Current Pharmaceutical Biotechnology
|
Hironori Nakagami; Naruya Tomita; Yasufumi Kaneda; Toshio Ogihara; Ryuichi Morishita
|
10.2174/138920106776597702
|
14
|
108 |
The RING-Finger Protein Haprin: Domains and Function in the Acrosome Reaction
|
Current Protein & Peptide Science
|
Kouichi Kitamura; Hiromitsu Tanaka; Yoshitake Nishimune
|
10.2174/138920305774933277
|
8
|
109 |
1,2,4,5-Tetraoxacycloalkanes: synthesis and antimalarial activity.
|
Mini Reviews In Medicinal Chemistry
|
Araki Masuyama; Jin Ming Wu; Masatomo Nojima; Hyo Sung Kim; Yusuke Wataya
|
10.2174/138955705774575255
|
26
|
110 |
Recent Progress in Cerebrovascular Gene Therapy
|
Current Neurovascular Research
|
Naoyuki Sato; Munehisa Shimamura; Ryuichi Morishita
|
10.2174/1567202054368353
|
0
|
111 |
Phage display and PEGylation of therapeutic proteins.
|
Combinatorial Chemistry & High Throughput Screening
|
Yohei Mukai; Yasuo Yoshioka; Yasuo Tsutsumi
|
10.2174/1386207053258578
|
12
|
112 |
Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.
|
Current Diabetes Reviews
|
Hironori Nakagami; Yasufumi Kaneda; Toshio Ogihara; Ryuichi Morishita
|
10.2174/1573399052952550
|
105
|
113 |
Oxidative stress and the JNK pathway in diabetes.
|
Current Diabetes Reviews
|
Hideaki Kaneto; Taka-aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Munehide Matsuhisa; Yoshimitsu Yamasaki
|
10.2174/1573399052952613
|
78
|
114 |
Application of decoy oligodeoxynucleotides-based approach to renal diseases.
|
Current Drug Targets
|
Naruya Tomita; Haruhito Azuma; Yasufumi Kaneda; Toshio Ogihara; Ryuichi Morishita
|
10.2174/1389450043345146
|
18
|
115 |
Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach.
|
Current Vascular Pharmacology
|
Yasuo Yoshioka; Yasuo Tsutsumi; Shinsaku Nakagawa; Tadanori Mayumi
|
10.2174/1570161043385682
|
15
|
116 |
Therapeutic angiogenesis using hepatocyte growth factor (HGF).
|
Current Gene Therapy
|
Ryuichi Morishita; Motokuni Aoki; Naotaka Hashiya; Keita Yamasaki; Hitomi Kurinami; Shiro Shimizu; Hirofumi Makino; Yasushi Takesya; Junya Azuma; Toshio Ogihara
|
10.2174/1566523043346453
|
94
|
117 |
Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles.
|
Current Drug Targets. Infectious Disorders
|
Tadanori Yamada; Masakazu Ueda; Masaharu Seno; Akihiko Kondo; Katsuyuki Tanizawa; Shun'ichi Kuroda
|
10.2174/1568005043341037
|
20
|
118 |
Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases.
|
Current Pharmaceutical Design
|
Naruya Tomita; Ryuichi Morishita
|
10.2174/1381612043452965
|
22
|
119 |
The role of estrogen and estrogen-related drugs in cardiovascular diseases.
|
Current Drug Metabolism
|
Hisakazu Ogita; Koichi Node; Masafumi Kitakaze
|
10.2174/1389200033489271
|
13
|
120 |
Regulation of Dendritic Cell Function Through Toll-like Receptors
|
Current Molecular Medicine
|
Tsuneyasu Kaisho; Shizuo Akira
|
10.2174/1566524033479366
|
272
|
121 |
Transcription factor as molecular targets: is transcription factor decoy a novel drug?
|
Current Drug Targets
|
Ryuichi Morishita
|
10.2174/1389450033490812
|
0
|
122 |
New vector innovation for drug delivery: development of fusigenic non-viral particles.
|
Current Drug Targets
|
Yasufumi Kaneda
|
10.2174/1389450033490740
|
37
|
123 |
Transcription factors as molecular targets : molecular mechanisms of decoy ODN and their design
|
Current Drug Targets
|
Naruya Tomita; Toshio Ogihara; Ryuichi Morishita
|
10.2174/1389450033490803
|
38
|
124 |
Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
|
Current Drug Targets
|
Motokuni Aoki; Ryuichi Morishita; Toshio Ogihara
|
10.2174/1389450033490830
|
1
|
125 |
IL-6 and Crohn's disease.
|
Current Drug Targets. Inflammation And Allergy
|
Hiroaki Ito
|
10.2174/1568010033484296
|
49
|
126 |
Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases
|
Current Drug Targets
|
Naruya Tomita; Haruhito Azuma; Yasufumi Kaneda; Toshio Ogihara; Ryuichi Morishita
|
10.2174/1389450033491055
|
15
|
127 |
Pathophysiological role of proteasome-dependent proteolytic pathway in endothelin-1-related cardiovascular diseases.
|
Current Vascular Pharmacology
|
Masanori Takaoka; Mamoru Ohkita; Yasuo Matsumura
|
10.2174/1570161033386637
|
15
|
128 |
Anti-interleukin-6 therapy for Crohn's disease.
|
Current Pharmaceutical Design
|
H. Ito
|
10.2174/1381612033391900
|
35
|
129 |
Application of In Vivo Electroporation to Cancer Gene Therapy
|
Current Gene Therapy
|
Takahiko Tamura; Tsuneaki Sakata
|
10.2174/1566523033347462
|
26
|
130 |
Gene therapy for ischemic brain diseases.
|
Current Gene Therapy
|
Youichi Saitoh; Amami Kato; Yasushi Hagihara; Yasufumi Kaneda; Toshiki Yoshimine
|
10.2174/1566523033347561
|
9
|
131 |
HMG-Co A Reductase Inhibitors in the Treatment of Cardiovascular Diseases: Stabilization of Coronary Artery Plaque
|
Current Drug Targets
|
Ryuichi Morishita; Naruya Tomita; Toshio Ogihara
|
10.2174/1389450023347434
|
10
|
132 |
Molecular design of bioconjugated cell adhesion peptide with a water-soluble polymeric modifier for enhancement of antimetastatic effect.
|
Current Drug Targets
|
Yoko Yamamoto; Yasuo Tsutsumi; Tadanori Mayumi
|
10.2174/1389450024605427
|
31
|
133 |
WT1 as a novel target antigen for cancer immunotherapy.
|
Current Cancer Drug Targets
|
Yoshihiro Oka; Akihiro Tsuboi; Olga A. Elisseeva; Keiko Udaka; Haruo Sugiyama
|
10.2174/1568009023334088
|
65
|
134 |
Gene therapy: a battle against biological barriers.
|
Current Molecular Medicine
|
Yasufumi Kaneda
|
10.2174/1566524013363519
|
28
|
135 |
Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?
|
Current Drug Targets
|
Ryuichi Morishita; Motokuni Aoki; Yasufumi Keneda
|
10.2174/1389450003349344
|
16
|
136 |
Flavonoids for allergic diseases: present evidence and future perspective.
|
Current Pharmaceutical Design
|
Toshio Tanaka
|
10.2174/13816128113199990060
|
24
|